Efficacy and Safety of Statins for Secondary Stroke Prevention in Patients With Cerebral Microbleeds: Jury Is Still Out

Neurology. 2024 Apr 9;102(7):e209261. doi: 10.1212/WNL.0000000000209261. Epub 2024 Mar 12.

Authors

Zurab Nadareishvili¹, Aristeidis H Katsanos¹, Ashkan Shoamanesh¹

Affiliation

¹ From the Department of Neurology and Rehabilitation Medicine (Z.N.), The George Washington University School of Medicine and Health Sciences, Washington, DC, and Comprehensive Stroke Center, VHC Health, Arlington, VA; and Department of Medicine-Neurology (A.H.K., A.S.), McMaster University / Population Health Research Institute, Hamilton, ON, Canada.

PMID: 38471050
DOI: 10.1212/WNL.0000000000209261

No abstract available

Publication types

Editorial

MeSH terms

Cerebral Hemorrhage / complications
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Magnetic Resonance Imaging
Secondary Prevention
Stroke* / complications

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors